TrialPath
Recruiting

Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial

NCT07725250 · National Bureau of Economic Research, Inc.
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
This study evaluates a new digital health program that uses artificial intelligence (AI) to help patients lower their blood pressure through personalized lifestyle recommendations. The program collects information about patients' daily habits and blood pressure readings, then uses AI to suggest lifestyle changes that may work best for each person. The study will measure how well this program works across different groups of patients and aims to improve the program design to make it more effective and easier to use. The program will be offered to diverse patients at UC San Diego Health, including people of different ages, genders, races/ethnicities, and economic backgrounds, as part of their regular healthcare services.
Eligibility criteria
Inclusion Criteria: * Stage I-II hypertension (average clinical readings of blood pressure over 140/90) * Adequate decisional capacity to make a choice about participating in this research study * Fully ambulatory (not requiring assistive device such as a cane, wheelchair, walker, etc.) Exclusion Criteria: * Pregnancy * Under age 18 years * Institutionalized individuals who are likely to be vulnerable * Dependent on supplemental oxygen
Study design
Enrollment target: 3000 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2026-04-10
Estimated completion: 2027-04-30
Last updated: 2026-07-24
Interventions
Other: Digital heath toolOther: Low-intensity recommendationOther: High-intensity recommendation
Primary outcomes
  • Systolic blood pressure measurement (6 months)
Sponsor
National Bureau of Economic Research, Inc. · other
With: National Institute on Aging (NIA), University of California, San Diego
Contacts & investigators
ContactAmanda Walker · contact · Alw038@health.ucsd.edu · 617-588-1445
ContactRoss Graham · contact · rograham@health.ucsd.edu
InvestigatorItzik Fadlon · principal_investigator, National Bureau of Economic Research, Inc.
InvestigatorMing Tai-Seale · principal_investigator, University of California, San Diego
All locations (1)
University of California, San DiegoRecruiting
La Jolla, California, United States
Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial · TrialPath